期刊文献+

人类野生型及突变型PPARγ基因真核表达质粒的构建和鉴定 被引量:2

Construction and identification of eukaryotic expression plasmids of human wild-type and mutant PPARγ gene
原文传递
导出
摘要 目的构建人类野生型过氧化物酶增殖物激活受体γ(PPARγ)及其突变型PPARγMut基因的真核表达质粒。方法采用RT-PCR和重叠延伸PCR技术扩增人类野生型及功能区缺失的突变型PPARγ全长序列,通过DNA重组技术分别将其重组于pcDNA3.1-Myc载体,构建myc标记的PPARγWT及PPARγMut融合蛋白表达质粒,通过酶切电泳分析和DNA测序的方法对重组表达质粒进行鉴定。结果通过酶切电泳和测序结果证实,构建的重组表达质粒目的基因片段为人类野生型PPARγ及突变型PPARγMut的cDNA。结论成功构建野生型及其功能区缺失的突变型PPARγ质粒,为进一步探讨PPARγ基因在乳腺癌发生和发展中的作用奠定了基础。 Objective To construct the eukaryotic expression plasmids of human wild-type peroxidase proliferator activated receptor γ(PPARγ) and its mutant PPARγMut gene.Methods The full sequences of wild-type and mutant PPARγ were amplified by RT-PCR and overlap extension PCR technique,which were then reconstructed into the eukaryotic expression vector pcDNA3.1-Myc to form the myc-tagged fusion protein expression plasmids of PPARγWT and PPARγMut by DNA recombinant technology.The recombinant expression plasmids were identified by enzyme digestion and DNA sequencing analysis.Results The enzyme digestion and DNA sequencing analysis showed that the constructed gene fragments of recombinant expression plasmids were the cDNA of human wild-type PPARγ and its mutant PPARγMut.Conclusion The plasmids of wild-type and mutant PPARγ have been successfully constructed,which lays a foundation for further exploring the role of PPARγ gene in the development and progression of breast cancer.
作者 邹琳 兰建云 宋曙 邵伟伟 陈海涛 江颖 ZOU Lin;LAN Jianyun;SONG Shu(Translational Medical Center, First Hospital of Yancheng, Yancheng 224001, CHINA)
出处 《江苏医药》 CAS 2019年第3期221-225,F0002,共6页 Jiangsu Medical Journal
关键词 过氧化物酶增殖物激活受体Γ 基因克隆 乳腺 Peroxidase proliferator activated receptor γ Gene cloning Breast
  • 相关文献

参考文献1

二级参考文献56

  • 1Herschman HR. Prostaglandin synthase 2. Biochem Bioph Acta 1996; 1299:125-140.
  • 2Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (part II). J Natl Cancer Inst 1998; 90:1609-1620.
  • 3Eberhart CE, Coffery RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107:1183-1188.
  • 4Hao X, Bishop AE, Wallace M, Wang H, Willcocks TC, Maclouf J, Polak JM, Knight S, Talbot IC. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 1999;187:295-301.
  • 5Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cylooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998; 58:2929-2934.
  • 6Ristimaki A, Honkanen N, Jankala H. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-1280.
  • 7Wolff H, Ssukkonen K, Anttila S, Karjalainen A, Vainio H,Restimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998; 58:4997-5001.
  • 8Mohammed SI, Knapp DW, Bostwick DG, Foster RS, Khan KN,Masferrer JL, Woerner BM, Snyder PW, Koki AT. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res 1999; 59: 5647-5650.
  • 9Tsujii M, DuBois RN. Alterations in celluar adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83:493-501.
  • 10DuBois RN, Shao J, Tsujii M, Sheng H, Beauchamp RD. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 1996; 56:733-737.

共引文献13

同被引文献11

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部